Literature DB >> 12628046

Mast cells in the pathogenesis of fibrosis.

Barry L Gruber1.   

Abstract

It has been appreciated for quite some time that a "round cell" inflammatory infiltrate is present in the dermis during the early stages of scleroderma. Considerable research has emanated from this basic observation, with the assumption that interactions between immune cells and fibroblasts are paramount in the genesis of fibrosis. The large number of mast cells that accumulate early in involved tissues has been less appreciated in recent studies. The purpose of this update is to demonstrate how mast cells interact with fibroblasts in a manner that leads to fibroblast activation and subsequent extracellular fibrosis. Furthermore, the notion that myofibroblasts represent a critical fibroblast phenotype in sclerosing disorders, such as scleroderma, has also gained considerable support. The relationship of tissue mast cells to the generation of a myofibroblast phenotype has been the focus of several recent reports and will also be discussed.

Entities:  

Mesh:

Year:  2003        PMID: 12628046     DOI: 10.1007/s11926-003-0043-3

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.686


  57 in total

Review 1.  The stem cell factor, its properties and potential role in the airways.

Authors:  O Kassel; C da Silva; N Frossard
Journal:  Pulm Pharmacol Ther       Date:  2001       Impact factor: 3.410

Review 2.  Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.

Authors:  O Déry; C U Corvera; M Steinhoff; N W Bunnett
Journal:  Am J Physiol       Date:  1998-06

3.  Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts.

Authors:  J A Cairns; A F Walls
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

4.  Ketotifen prevents skin fibrosis in the tight skin mouse.

Authors:  M Walker; R Harley; E C LeRoy
Journal:  J Rheumatol       Date:  1990-01       Impact factor: 4.666

Review 5.  Regulation of mast cell number and function.

Authors:  A Kirshenbaum
Journal:  Hematol Oncol Clin North Am       Date:  2000-06       Impact factor: 3.722

6.  Mast cell tryptase: a new target for therapeutic intervention in asthma.

Authors:  R D Tanaka; J M Clark; R L Warne; W M Abraham; W R Moore
Journal:  Int Arch Allergy Immunol       Date:  1995 May-Jun       Impact factor: 2.749

7.  Mast cells in rapidly progressive glomerulonephritis.

Authors:  T Tóth; R Tóth-Jakatics; S Jimi; M Ihara; H Urata; S Takebayashi
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

8.  Different interaction of mast cells with human endothelial cells and fibroblasts.

Authors:  T Ohtsuka
Journal:  Eur J Dermatol       Date:  2000-03       Impact factor: 3.328

9.  Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1.

Authors:  T Z Kirk; M E Mark; C C Chua; B H Chua; M D Mayes
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

10.  Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha.

Authors:  J R Gordon; S J Galli
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  30 in total

1.  Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.

Authors:  Verena D Schwab; Mathias Sulk; Stephan Seeliger; Pawel Nowak; Jerome Aubert; Christian Mess; Michel Rivier; Isabelle Carlavan; Patricia Rossio; Dieter Metze; Jörg Buddenkotte; Ferda Cevikbas; Johannes J Voegel; Martin Steinhoff
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

2.  Elastofibroma: a histochemical, immunohistochemical, and ultrastructural study of two patients.

Authors:  Naoto Kuroda; Nobumasa Hamaguchi; Masahiko Ohara; Takashi Hirouchi; Keiko Mizuno; Yoshihiro Hayashi; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2008-09-20       Impact factor: 2.309

Review 3.  Cytokines in the immunopathology of systemic sclerosis.

Authors:  Jasmin Raja; Christopher Paul Denton
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

4.  Reduction of arthrofibrosis utilizing a collagen membrane drug-eluting scaffold with celecoxib and subcutaneous injections with ketotifen.

Authors:  Afton K Limberg; Meagan E Tibbo; Christopher G Salib; Alex R McLaury; Travis W Turner; Charlotte E Berry; Anthony G Jay; Jodi M Carter; Brad Bolon; Daniel J Berry; Mark E Morrey; Joaquin Sanchez-Sotelo; Andre J van Wijnen; Matthew P Abdel
Journal:  J Orthop Res       Date:  2020-03-11       Impact factor: 3.494

Review 5.  Mast cell activity in the healing wound: more than meets the eye?

Authors:  Brian C Wulff; Traci A Wilgus
Journal:  Exp Dermatol       Date:  2013-06-27       Impact factor: 3.960

Review 6.  The Importance of Mast Cells in Dermal Scarring.

Authors:  Traci A Wilgus; Brian C Wulff
Journal:  Adv Wound Care (New Rochelle)       Date:  2014-04-01       Impact factor: 4.730

Review 7.  Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.

Authors:  Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

8.  Diagnostic and therapeutic strategies for eosinophilic esophagitis.

Authors:  Asifa K Zaidi; Ahad Mussarat; Anil Mishra
Journal:  Clin Pract (Lond)       Date:  2014

Review 9.  Secondary sclerosing cholangitis.

Authors:  Petra Ruemmele; Ferdinand Hofstaedter; Cornelia M Gelbmann
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

10.  Role of mast cells in fibrosis of classical Hodgkin lymphoma.

Authors:  Shoko Nakayama; Taiji Yokote; Nobuya Hiraoka; Uta Nishiwaki; Toshiaki Hanafusa; Yasuichiro Nishimura; Motomu Tsuji
Journal:  Int J Immunopathol Pharmacol       Date:  2016-04-19       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.